Table 1.
Variable | Total | Gastrointestinal Diagnoses |
Febrile Illness |
Dermatologic Diagnoses |
Respiratory or Pharyngeal Diagnoses |
Neurologic Diagnoses |
GU, STI, and Gynecologic Diagnoses |
---|---|---|---|---|---|---|---|
Travelers, n (%) | 42 173 | 14 346 (34.0) | 9817 (23.3) | 8227(19.5) | 4613 (10.9) | 724 (1.7) | 1209 (2.9) |
Diagnoses, n * | 49 379 | 14 837 | 10 092 | 9669 | 4851 | 738 | 1260 |
Men, % † | 49.9 | 44.5 | 58.9 | 47.8 | 51.7 | 50.6 | 37.2 |
Median age (range), y ‡ | 34 (0–95) | 32 (0–92) | 35 (0–91) | 35 (0–95) | 36 (0–93) | 38 (0–88) | 37 (0–88) |
Travel reason, % § | |||||||
Tourism | 55.7 | 59.3 | 45.1 | 68.2 | 53.6 | 55.4 | 51.9 |
Business | 13.6 | 14.2 | 14.2 | 9.5 | 17.0 | 12.8 | 13.9 |
Visiting friends/relatives | 15.5 | 8.8 | 28.1 | 10.2 | 16.5 | 13.5 | 18.5 |
Missionary | 11.6 | 13.9 | 8.7 | 8.4 | 9.2 | 13.5 | 13.1 |
Student | 2.6 | 3.4 | 2.0 | 2.5 | 2.9 | 4.0 | 1.9 |
Region, % ∥ | |||||||
Australia and New Zealand | 0.5 | 0.2 | 0.2 | 0.7 | 1.8 | 0.7 | 0.6 |
Southeast Asia | 16.3 | 13.8 | 18.1 | 22.0 | 17.4 | 10.1 | 17.3 |
South-Central Asia | 13.6 | 19.1 | 13.2 | 9.1 | 10.6 | 7.6 | 11.1 |
Northeast Asia | 2.7 | 2.2 | 1.2 | 2.9 | 5.8 | 3.2 | 2.4 |
Europe | 4.7 | 3.5 | 2.1 | 4.7 | 10.1 | 9.3 | 7.4 |
Latin America and Caribbean | 19.2 | 20.4 | 14.3 | 27.3 | 14.2 | 23.6 | 15.6 |
Middle East and North Africa | 6.1 | 8.7 | 2.5 | 5.6 | 5.2 | 6.5 | 6.1 |
North America | 1.5 | 0.5 | 0.4 | 1.6 | 5.3 | 2.9 | 2.1 |
Oceania | 0.8 | 0.7 | 1.0 | 1.2 | 0.9 | 1.4 | 0.5 |
Sub-Saharan Africa | 26.7 | 22.5 | 42.6 | 19.5 | 20.6 | 22.3 | 26.9 |
GU = genitourinary; STI = sexually transmitted infection.
Some travelers had >1 diagnosis. Other diagnoses (adverse events to medication or vaccine, injury or musculoskeletal problems, opthalmologic or oral conditions, and psychological problems) are not shown (7932 diagnoses).
Data were missing in 36 cases (0.09%).
Data were missing in 143 cases (0.3%).
Data were missing in 22 cases (0.05%), and alternate reason (military or medical tourism) accounted for 1%.
Region of illness acquisition not ascertainable in 3299 cases (7.8%).